$GILBearishMed

T - shirt maker Gildan plunges on short seller revenue claim

Gildan Activewear shares fell sharply after short seller Jehoshaphat Research alleged “channel stuffing” that inflates revenue. Jehoshaphat said interviews and accounting analysis indicate sales were pulled forward, potentially causing a 20% miss versus analysts’ H2 estimates. Gildan denied the claims, reiterated fiscal 2026 guidance, and said disclosures are accurate.

7/10
4/10
Med
Bearish
Tuesday intraday selloff after Jehoshaphat Research published the negative report
Bearish—short-seller revenue-inflation claim drove the sharp drop despite management reiterating guidance

The report raises near-term earnings risk by challenging the quality of reported revenue and implying future demand cannibalization.

Gildan shares plunged after Jehoshaphat Research alleged revenue inflation via channel stuffing and forecast a 20% H2 sales miss.

Elevated downside volatility likely persists until management addresses the allegations and investors reassess 2H revenue/earnings risk.

Background

Jehoshaphat Research is a short seller that previously accused Goeasy of delaying bad-loan recognition; Goeasy later disclosed large loan losses after denial.

Why it matters

The article frames the selloff as a reassessment of revenue quality (channel stuffing) and potential downstream demand cannibalization, with management disputing the claim while maintaining guidance.

Market relevance

A negative short-seller accounting/revenue-quality claim triggered a large intraday drawdown, increasing near-term uncertainty around 2H sales and earnings trajectory.

Market effects

Highlights apparel/consumer-goods channel-stuffing risk and the market’s sensitivity to revenue-recognition integrity.

Toronto-listed trading saw the largest intraday move in years, potentially increasing Canadian small/mid-cap risk appetite toward similar names.

If credible, could pressure read-across for other apparel distributors/manufacturers on reported growth quality.

Alternative perspectives

UBS analysts cited in the article view the report as a buying opportunity and expect no 2026 revenue guidance miss, implying the market may be overreacting to a contested accounting narrative.

Management’s statement reiterates fiscal 2026 guidance; the next key catalyst is whether Gildan provides additional disclosure at its December analyst day to rebut or quantify the alleged pull-forward impact.

Key entities

  • Gildan Activewear Inc.

    Apparel manufacturer whose shares fell sharply after a short-seller report alleged revenue inflation via channel stuffing.

  • Jehoshaphat Research

    Short seller alleging Gildan inflates revenue by selling more product than necessary into distribution channels.

  • UBS

    Cited as viewing the decline as a buying opportunity and expecting no 2026 revenue guidance miss.

Related articles

$GILMed

Gildan Activewear Inc. (GIL) Shares Tumble 18% Amid Activist Forensic Report Challenging Company's Business Practices And Potentially Improper Revenue Recognition -- HBSS

Gildan Activewear (NYSE: GIL) shares fell about 18% on June 16 after Jehoshaphat Research published a forensic report alleging improper channel stuffing and potentially improper revenue recognition, wiping out about $2.15B in market cap. Hagens Berman opened an investigation into whether the claims are accurate and whether securities laws were violated.

$GILMed

2026 - 06 - 22 | Levi & Korsinsky Announces Investigation of Securities Claims Against Gildan Activewear (GIL) | TSX: GIL

Levi & Korsinsky announced it is investigating potential securities claims against Gildan Activewear (NYSE: GIL) after Jehoshaphat Research alleged the company channel-stuffed distributors, with about $510 million in excess inventory. GIL shares fell 18.77% in one session on June 16, after the report. Gildan said it was “confident” its FY2026 guidance and disclosures were accurate, according to the company.

$GILMed

Why Gildan Activewear Stock Tumbled by 11% This Week

Jehoshaphat Research, a short seller holding a 4% short position in Gildan Activewear’s total float, published a 60-page bearish report on Tuesday alleging issues including “channel stuffing,” and possible tax and accounting irregularities. Gildan’s stock fell 11% for the week, according to S&P Global Market Intelligence. Gildan said it is confident its disclosures are accurate and comprehensive.

$GILMed

Gildan is down, and looking good

A U.S. short-seller, Jehoshaphat Research, issued a bearish report on Gildan Activewear (GIL-T), alleging “channel stuffing” that could pull forward sales and hurt revenue in the second half of 2026. Gildan said its disclosures are accurate. Shares fell 19% Tuesday. Scotia cut its 12-month target to $65 from $72.

$GILMed

Gildan Activewear Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Gildan Activewear (GIL)

Jehoshaphat Research alleged Gildan Activewear (NYSE: GIL) had about $510 million in excess distributor inventory, and GIL shares fell about 18.77% on June 17, 2026. The report said the allegation conflicts with CEO Glenn Chamandy’s prior statements that channel inventory was “in balance” and “healthy.” Gildan reported nearly $1.2 billion in Q1 2026 net sales. Levi & Korsinsky said it is investigating potential securities law violations.

$GILMed

Benzinga

A Jehoshaphat Research short report says Gildan’s true organic growth over three years averaged a 3% annual decline, not a 1% increase, citing off-balance-sheet receivables factoring. It claims Days Sales Outstanding rises to 129 days company-wide and 195 at S&S. The report warns of an $800 million H2 2026 revenue gap, governance concerns involving CEO Glenn Chamandy, and resignations from an ethics committee. Gildan shares fell 20.9% to $49.02.